Abstract:Alzheimer’s disease (AD) and AD-related dementias (ADRD) are a class of neurodegenerative diseases affecting about 5.7 million Americans. There is no cure for AD/ADRD. Current interventions have modest effects and focus on attenuating cognitive impairment. Detection of patients at high risk of AD/ADRD is crucial for timely interventions to modify risk factors and primarily prevent cognitive decline and dementia, and thus to enhance the quality of life and reduce health care costs. This study seeks to investigate both knowledge-driven (where domain experts identify useful features) and data-driven (where machine learning models select useful features among all available data elements) approaches for AD/ADRD early prediction using real-world electronic health records (EHR) data from the University of Florida (UF) Health system. We identified a cohort of 59,799 patients and examined four widely used machine learning algorithms following a standard case-control study. We also examined the early prediction of AD/ADRD using patient information 0-years, 1-year, 3-years, and 5-years before the disease onset date. The experimental results showed that models based on the Gradient Boosting Trees (GBT) achieved the best performance for the data-driven approach and the Random Forests (RF) achieved the best performance for the knowledge-driven approach. Among all models, GBT using a data-driven approach achieved the best area under the curve (AUC) score of 0.7976, 0.7192, 0.6985, and 0.6798 for 0, 1, 3, 5-years prediction, respectively. We also examined the top features identified by the machine learning models and compared them with the knowledge-driven features identified by domain experts. Our study demonstrated the feasibility of using electronic health records for the early prediction of AD/ADRD and discovered potential challenges for future investigations. ### Competing Interest Statement The authors have declared no competing interest. ### Funding Statement This study was partially supported by an Ed and Ethel Moore Alzheimer's Disease Research Program from the Florida Department of Health (FL DOH #9AZ14) and a Patient-Centered Outcomes Research Institute (PCORI) Award (ME-2018C3-14754). The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding institutions. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The University of Florida IRB (IRB201900182) had approved this study and assigned to the exempt category. All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable. Yes Data sharing is not applicable to this article.

Pretrained Patient Trajectories for Adverse Drug Event Prediction Using Common Data Model-based Electronic Health Records

A Method for the Early Prediction of Chronic Diseases Based on Short Sequential Medical Data.

Electronic health record-based prediction models for in-hospital adverse drug event diagnosis or prognosis: a systematic review

CT-ADE: An Evaluation Benchmark for Adverse Drug Event Prediction from Clinical Trial Results

Use of deep learning to develop continuous-risk models for adverse event prediction from electronic health records

Development of a prediction models for chemotherapy-induced adverse drug reactions: A retrospective observational study using electronic health records

Predicting the physiological effects of multiple drugs using electronic health record

Adverse Drug Event Detection from Electronic Health Records Using Hierarchical Recurrent Neural Networks with Dual-Level Embedding

Treatment effect prediction with adversarial deep learning using electronic health records

Abstract 4923: A systematic framework for predicting adverse drug reaction signals using medical data

AEP-DLA: Adverse Event Prediction in Hospitalized Adult Patients Using Deep Learning Algorithms

Using Machine Learning and Electronic Health Record (EHR) Data for the Early Prediction of Alzheimer's Disease and Related Dementias.

Personalized Event Prediction for Electronic Health Records

Early Prediction of Alzheimer’s Disease and Related Dementias Using Electronic Health Records

Developing A Deep Learning Natural Language Processing Algorithm For Automated Reporting Of Adverse Drug Reactions

Extraction of Information Related to Adverse Drug Events from Electronic Health Record Notes: Design of an End-to-End Model Based on Deep Learning

Extraction of Information Related to Drug Safety Surveillance From Electronic Health Record Notes: Joint Modeling of Entities and Relations Using Knowledge-Aware Neural Attentive Models (Preprint)

ADEP: A Novel Approach Based on Discriminator-Enhanced Encoder-Decoder Architecture for Accurate Prediction of Adverse Effects in Polypharmacy

Scalable and accurate deep learning with electronic health records

Electronic Health Records-Based Data-Driven Diabetes Knowledge Unveiling and Risk Prognosis

Adverse drug event and medication extraction in electronic health records via a cascading architecture with different sequence labeling models and word embeddings